We reviewed our experiences with concurrent chemoradiotherapy (CCRT) treatment for patients with resectable squamous cell carcinoma (SCC) of the hypopharynx and considered the indication of CCRT for this disease. The survival rates of stage I–II hypopharyngeal SCC patients treated with radiotherapy alone were reported to be adequate. CCRT may be applied to improve the laryngeal preservation rate for stage II disease. We reported that the chemotherapy regimen and the N staging could predict the treatment outcomes of patients with advanced stage. The indication of CCRT was able to be determined by these factors. A functioning larynx could be preserved in most of the patients with hypopharyngeal SCC treated with CCRT according to our previous reports on the evaluation of laryngeal functions after CCRT.